264 related articles for article (PubMed ID: 21247883)
1. Wide-ranging functions of E2F4 in transcriptional activation and repression revealed by genome-wide analysis.
Lee BK; Bhinge AA; Iyer VR
Nucleic Acids Res; 2011 May; 39(9):3558-73. PubMed ID: 21247883
[TBL] [Abstract][Full Text] [Related]
2. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
Li JM; Hu PP; Shen X; Yu Y; Wang XF
Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
[TBL] [Abstract][Full Text] [Related]
3. E2F4 regulates transcriptional activation in mouse embryonic stem cells independently of the RB family.
Hsu J; Arand J; Chaikovsky A; Mooney NA; Demeter J; Brison CM; Oliverio R; Vogel H; Rubin SM; Jackson PK; Sage J
Nat Commun; 2019 Jul; 10(1):2939. PubMed ID: 31270324
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members.
Xu X; Bieda M; Jin VX; Rabinovich A; Oberley MJ; Green R; Farnham PJ
Genome Res; 2007 Nov; 17(11):1550-61. PubMed ID: 17908821
[TBL] [Abstract][Full Text] [Related]
5. p110 CUX1 cooperates with E2F transcription factors in the transcriptional activation of cell cycle-regulated genes.
Truscott M; Harada R; Vadnais C; Robert F; Nepveu A
Mol Cell Biol; 2008 May; 28(10):3127-38. PubMed ID: 18347061
[TBL] [Abstract][Full Text] [Related]
6. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
Araki K; Nakajima Y; Eto K; Ikeda MA
Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
[TBL] [Abstract][Full Text] [Related]
7. Anti-apoptotic function of the E2F transcription factor 4 (E2F4)/p130, a member of retinoblastoma gene family in cardiac myocytes.
Dingar D; Konecny F; Zou J; Sun X; von Harsdorf R
J Mol Cell Cardiol; 2012 Dec; 53(6):820-8. PubMed ID: 22985930
[TBL] [Abstract][Full Text] [Related]
8. Coordinated repression of cell cycle genes by KDM5A and E2F4 during differentiation.
Beshiri ML; Holmes KB; Richter WF; Hess S; Islam AB; Yan Q; Plante L; Litovchick L; Gévry N; Lopez-Bigas N; Kaelin WG; Benevolenskaya EV
Proc Natl Acad Sci U S A; 2012 Nov; 109(45):18499-504. PubMed ID: 23093672
[TBL] [Abstract][Full Text] [Related]
9. Tripartite motif containing 28 (Trim28) can regulate cell proliferation by bridging HDAC1/E2F interactions.
Chen L; Chen DT; Kurtyka C; Rawal B; Fulp WJ; Haura EB; Cress WD
J Biol Chem; 2012 Nov; 287(48):40106-18. PubMed ID: 23060449
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1/cdk4 can interact with E2F4/DP1 and disrupts its DNA-binding capacity.
Scimè A; Li L; Ciavarra G; Whyte P
J Cell Physiol; 2008 Mar; 214(3):568-81. PubMed ID: 17894419
[TBL] [Abstract][Full Text] [Related]
11. Competitive regulation by transcription factors and DNA methylation in the bovine SIRT5 promoter: Roles of E2F4 and KLF6.
Hong J; Wang X; Mei C; Zan L
Gene; 2019 Feb; 684():39-46. PubMed ID: 30359737
[TBL] [Abstract][Full Text] [Related]
12. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
13. Dynamic transcriptional regulatory complexes, including E2F4, p107, p130, and Sp1, control fibroblast growth factor receptor 1 gene expression during myogenesis.
Parakati R; DiMario JX
J Biol Chem; 2005 Jun; 280(22):21284-94. PubMed ID: 15811856
[TBL] [Abstract][Full Text] [Related]
14. Differential activities of E2F family members: unique functions in regulating transcription.
Pierce AM; Schneider-Broussard R; Philhower JL; Johnson DG
Mol Carcinog; 1998 Jul; 22(3):190-8. PubMed ID: 9688145
[TBL] [Abstract][Full Text] [Related]
15. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
Fischer M; Quaas M; Nickel A; Engeland K
Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
[TBL] [Abstract][Full Text] [Related]
16. The transcription factor p53: not a repressor, solely an activator.
Fischer M; Steiner L; Engeland K
Cell Cycle; 2014; 13(19):3037-58. PubMed ID: 25486564
[TBL] [Abstract][Full Text] [Related]
17. The von Hippel Lindau tumour suppressor gene is a novel target of E2F4-mediated transcriptional repression in preeclampsia.
Alahari S; Garcia J; Post M; Caniggia I
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3298-3308. PubMed ID: 30053437
[TBL] [Abstract][Full Text] [Related]
18. Novel functions for the transcription factor E2F4 in development and disease.
Hsu J; Sage J
Cell Cycle; 2016 Dec; 15(23):3183-3190. PubMed ID: 27753528
[TBL] [Abstract][Full Text] [Related]
19. Differences in DNA binding properties between E2F1 and E2F4 specify repression of the Mcl-1 promoter.
Croxton R; Ma Y; Cress WD
Oncogene; 2002 Feb; 21(10):1563-70. PubMed ID: 11896585
[TBL] [Abstract][Full Text] [Related]
20. Multilayered chromatin analysis reveals E2f, Smad and Zfx as transcriptional regulators of histones.
Gokhman D; Livyatan I; Sailaja BS; Melcer S; Meshorer E
Nat Struct Mol Biol; 2013 Jan; 20(1):119-26. PubMed ID: 23222641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
